1-5 of 5
M. Liberati, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Met Over-Expression Is a Prognostic Factor for Myeloma Patients Treated with Novel Agents.

Albero Rocci, MD, Francesca Gay, MD, Livio Trusolino, MD, Paola Omedè€, PhD, Andrea Bertotti, MD, Vittorio Montefusco, MD, Claudia Crippa, MD, Francesca Patriarca, MD, Milena Gilestro, PhD, Anna M. Liberati, MD, Fausto Rossini, MD, Tommaso Caravita, MD, Antonietta Falcone, MD, Giuseppe Rossi, MD, Daniela Drandi, PhD, Paolo Corradini, MD, Marco Ladetto, MD, Paolo M. Comoglio, MD, Mario Boccadoro, MD, Antonio Palumbo, MD
Journal: Blood
Blood (2009) 114 (22): 1821.
https://doi.org/10.1182/blood.V114.22.1821.1821
Published: 2009
Journal Articles

Bortezomib-Doxorubicin-Dexamethasone as Induction Prior to Reduced Intensity Autologous Transplantation Followed by Lenalidomide as Consolidation/Maintenance in Elderly Untreated Myeloma Patients

Antonio Palumbo, MD, Patrizia Falco, MD, Francesca Gay, MD, Vittorio Montefusco, MD, Claudia Crippa, MD, Francesca Patriarca, MD, Milena Gilestro, PhD, Anna M. Liberati, MD, Fausto Rossini, MD, Tommaso Caravita, MD, Antonietta Falcone, MD, Federica Cavallo, MD, Paolo Corradini, MD, Giuseppe Rossi, MD, Mario Boccadoro, MD
Journal: Blood
Blood (2008) 112 (11): 159.
https://doi.org/10.1182/blood.V112.11.159.159
Published: 2008
Journal Articles

Long-Term Follow-Up of the Randomized GITMO/IIL Trial Comparing CHOP-Rituximab vs. High-Dose Therapy with Rituximab (R-HDS) in High Risk Follicular Lymphoma (Fl): Updated Results Suggest the Use of R-HDS as Salvage Treatment.

Marco Ladetto, MD, Federica De Marco, MD, Fabio Benedetti, MD, Umberto Vitolo, MD, Caterina Patti, MD, Alessandro Rambaldi, MD, Alessandro Pulsoni, MD, Maurizio Musso, MD, Anna M. Liberati, MD, Attilio Olivieri, MD, Andrea Gallamini, MD, Enrico Pogliani, MD, Delia Rota Scalabrini, MD, Vincenzo Callea, MD, Francesco Di Raimondo, MD, Vincenzo Pavone, MD, Alessandra Tucci, MD, Sergio Cortelazzo, MD, Alessandro Levis, MD, Mario Boccadoro, MD, Ignazio Majolino, MD, Alessandro Pileri, MD, Alessandro M. Gianni, MD, Roberto Passera, PhD, Paolo Corradini, MD, Corrado Tarella, MD
Journal: Blood
Blood (2007) 110 (11): 20.
https://doi.org/10.1182/blood.V110.11.20.20
Published: 2007
Journal Articles

Bortezomib, Pegylated-Lyposomal-Doxorubicin and Dexamethasone Followed by Melphalan 100 mg/m 2 in Elderly Newly Diagnosed Patients: An Interim Analysis.

Antonio Palumbo, MD, Ilaria Avonto, MD, Francesca Patriarca, MD, Claudia Crippa, MD, Maria T. Petrucci, MD, Fausto Rossini, MD, Paolo Corradini, MD, Anna M. Liberati, MD, Nicola Giuliani, MD, Norbert Pescosta, MD, Patrizia Falco, MD, Alessandra Larocca, MD, Paola Omedè€, MD, Massimo Offidani, MD, Renato Fanin, MD, Mario Boccadoro, MD
Journal: Blood
Blood (2007) 110 (11): 448.
https://doi.org/10.1182/blood.V110.11.448.448
Published: 2007
Journal Articles

Anagrelide Treatment and Cardiovascular Evaluation in 130 Patients with Essential Thrombocythemia (ET): Preliminary Report of the Registro Italiano Trombocitemia (RIT).

Luigi Gugliotta, MD, A. Tieghi, MD, S. Bulgarelli, MD, G. Tortorella, MD, R. Ciancia, MD, P. R. Scalzulli, MD, E. Cacciola, MD, R. Cacciola, MD, D. Rossi, MD, E. Usala, MD, M. Crugnola, MD, A. Candoni, MD, M. Giordano, MD, A. Andriani, MD, C. Santoro, MD, R. Vimercati, MD, M. Liberati, MD, A. Sciorio, MD, G. Specchia, MD, V. Martinelli, MD, G. Gaidano, MD, M. G. Mazzucconi, MD
Journal: Blood
Blood (2005) 106 (11): 4956.
https://doi.org/10.1182/blood.V106.11.4956.4956
Published: 2005